{
  "ptid_time": "109_S_2278_2011-03-09",
  "img_path": "/data/qiuhui/data/adni/images/109_S_2278/2011-03-09/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 16,372 mm³, 34.5% below the reference mean. With a Z-score of -0.46 (32.3th percentile), this represents normal volume ; hippocampal volume measures 8,559 mm³.; whole brain volume measures 963,973 mm³, 19.1% below the reference mean. With a Z-score of -3.54 (0.0th percentile), this represents profound atrophy; entorhinal cortex volume measures 3,233 mm³, 19.2% below the reference mean. With a Z-score of -1.69 (4.6th percentile), this represents moderate atrophy; fusiform gyrus volume measures 16,541 mm³, 20.6% below the reference mean. With a Z-score of -3.14 (0.1th percentile), this represents profound atrophy; middle temporal gyrus volume measures 20,392 mm³.. ",
  "text_data": "Age is 56.0 years. Gender is Male. Education: 16 years. Medical history: Musculoskeletal; Major Surgical Procedures. MMSE: 29.0. MoCA: 24.0. Logical Memory: 10.0. APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 0.99 SUVR (normal ); Total tau: 264.40 pg/mL (normal ); Phosphorylated tau: 21.61 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The patient shows profound atrophy in whole brain volume and fusiform gyrus, along with moderate atrophy in the entorhinal cortex, which are key regions affected in Alzheimer's disease (AD). However, hippocampal volume is not explicitly reported as atrophic, and CSF biomarkers (T-tau, P-tau) and amyloid PET (AV45) are normal, which is atypical for AD. The MMSE is normal (29/30), but the MoCA (24/30) suggests mild cognitive impairment (MCI).  \n\n**Diagnosis:** **MCI** (given the MoCA score and structural atrophy, but normal biomarkers complicate a dementia diagnosis).  \n**Confidence:** **Medium** (due to conflicting imaging and biomarker findings).",
  "timestamp": "2025-07-26T11:32:23.512251"
}